4.40% -0.4709

4 D Molecular Therapeutics Inc (FDMT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der 4 D Molecular Therapeutics Inc-Aktie (FDMT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.14% 0.015	0.014	0.001	0.003	0.005
Operating Expenses	10.88% 59.47	53.63	56.12	51.13	42.46
Benefits Costs and Expenses	100.00% -	47.99	49.67	-	-
Costs And Expenses	23.93% 59.47	47.99	49.67	51.13	42.46
Depreciation and Amortization	10.94% 1.166	1.051	1.096	1.19	1.194
Operating Income/Loss	10.88% -59.46	-53.62	-56.12	-51.13	-42.46
Nonoperating Income/Loss	15.06% 4.798	5.649	6.446	7.289	7.503
Income/Loss From Continuing Operations Before Tax	100.03% 0.015	-47.97	-49.67	0.003	-34.95
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	13.94% -54.66	-47.97	-49.67	-43.84	-34.95
Net Income/Loss	13.94% -54.66	-47.97	-49.67	-43.84	-34.95
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.33% 55.93	55.74	0.566	55.55	55.28
Diluted Average Shares	0.33% 55.93	55.74	0.566	55.55	55.28
Basic Earnings Per Share	13.95% -0.98	-0.86	-0.90	-0.79	-0.63
Diluted Earnings Per Share	13.95% -0.98	-0.86	-0.90	-0.79	-0.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.70

1.11%

GMAB

$28.91

0.72%

INCY

$102.30

0.64%

BNTX

$104.01

0.05%

ONC

$310.12

0.56%

INSM

$183.72

1.36%